0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Atosiban Acetate Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-32W13546
Home | Market Reports | Health| Reproductive Health
Global Atosiban Acetate Injection Market Research Report 2023
BUY CHAPTERS

Global Atosiban Acetate Injection Market Research Report 2025

Code: QYRE-Auto-32W13546
Report
May 2025
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Atosiban Acetate Injection Market

The global market for Atosiban Acetate Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Atosiban Acetate Injection is a tocolytic that can be used in IVF to protect the pregnancy, and the principle of action is to prevent the increase of calcium ions in the cells, relax the smooth muscle of the uterus, reduce uterine contractions and help embryo implantation.
North American market for Atosiban Acetate Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Atosiban Acetate Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Atosiban Acetate Injection include Bachem, Piramal Pharma Solutions, Transo-Pharm, Rochem International, Suanfarma, Teva Pharmaceutical Industries, PolyPeptide Group, Emcure Pharmaceuticals, Smaart Pharmaceutticals, Omgene Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Atosiban Acetate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atosiban Acetate Injection.
The Atosiban Acetate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Atosiban Acetate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atosiban Acetate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Atosiban Acetate Injection Market Report

Report Metric Details
Report Name Atosiban Acetate Injection Market
Segment by Type
  • 0.9 ml
  • 5 ml
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bachem, Piramal Pharma Solutions, Transo-Pharm, Rochem International, Suanfarma, Teva Pharmaceutical Industries, PolyPeptide Group, Emcure Pharmaceuticals, Smaart Pharmaceutticals, Omgene Life Sciences, BCN Peptides, MSN Laboratories, Carbosynth, Tecoland, Jigs Chemical, LGM Pharma, Hangzhou Go Top Peptide Biotech, Sun Pharmaceutical lndustrie, Hainan Zhonghe, Shanghai SOHO YIMING, Hybio Pharmaceutical, Hainan Herui, Chengdu Shengnuo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Atosiban Acetate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Atosiban Acetate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Atosiban Acetate Injection Market report?

Ans: The main players in the Atosiban Acetate Injection Market are Bachem, Piramal Pharma Solutions, Transo-Pharm, Rochem International, Suanfarma, Teva Pharmaceutical Industries, PolyPeptide Group, Emcure Pharmaceuticals, Smaart Pharmaceutticals, Omgene Life Sciences, BCN Peptides, MSN Laboratories, Carbosynth, Tecoland, Jigs Chemical, LGM Pharma, Hangzhou Go Top Peptide Biotech, Sun Pharmaceutical lndustrie, Hainan Zhonghe, Shanghai SOHO YIMING, Hybio Pharmaceutical, Hainan Herui, Chengdu Shengnuo

What are the Application segmentation covered in the Atosiban Acetate Injection Market report?

Ans: The Applications covered in the Atosiban Acetate Injection Market report are Threatened Preterm Birth, Inhibits Lactation, Others

What are the Type segmentation covered in the Atosiban Acetate Injection Market report?

Ans: The Types covered in the Atosiban Acetate Injection Market report are 0.9 ml, 5 ml

Recommended Reports

Pharmaceutical Injections

Women's Health Treatments

Muscle and Cardio Therapy

1 Atosiban Acetate Injection Market Overview
1.1 Product Definition
1.2 Atosiban Acetate Injection by Type
1.2.1 Global Atosiban Acetate Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.9 ml
1.2.3 5 ml
1.3 Atosiban Acetate Injection by Application
1.3.1 Global Atosiban Acetate Injection Market Value by Application (2024 VS 2031)
1.3.2 Threatened Preterm Birth
1.3.3 Inhibits Lactation
1.3.4 Others
1.4 Global Atosiban Acetate Injection Market Size Estimates and Forecasts
1.4.1 Global Atosiban Acetate Injection Revenue 2020-2031
1.4.2 Global Atosiban Acetate Injection Sales 2020-2031
1.4.3 Global Atosiban Acetate Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Atosiban Acetate Injection Market Competition by Manufacturers
2.1 Global Atosiban Acetate Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Atosiban Acetate Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Atosiban Acetate Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Atosiban Acetate Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atosiban Acetate Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atosiban Acetate Injection, Product Type & Application
2.7 Global Key Manufacturers of Atosiban Acetate Injection, Date of Enter into This Industry
2.8 Global Atosiban Acetate Injection Market Competitive Situation and Trends
2.8.1 Global Atosiban Acetate Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Atosiban Acetate Injection Players Market Share by Revenue
2.8.3 Global Atosiban Acetate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Atosiban Acetate Injection Market Scenario by Region
3.1 Global Atosiban Acetate Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Atosiban Acetate Injection Sales by Region: 2020-2031
3.2.1 Global Atosiban Acetate Injection Sales by Region: 2020-2025
3.2.2 Global Atosiban Acetate Injection Sales by Region: 2026-2031
3.3 Global Atosiban Acetate Injection Revenue by Region: 2020-2031
3.3.1 Global Atosiban Acetate Injection Revenue by Region: 2020-2025
3.3.2 Global Atosiban Acetate Injection Revenue by Region: 2026-2031
3.4 North America Atosiban Acetate Injection Market Facts & Figures by Country
3.4.1 North America Atosiban Acetate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Atosiban Acetate Injection Sales by Country (2020-2031)
3.4.3 North America Atosiban Acetate Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Atosiban Acetate Injection Market Facts & Figures by Country
3.5.1 Europe Atosiban Acetate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Atosiban Acetate Injection Sales by Country (2020-2031)
3.5.3 Europe Atosiban Acetate Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atosiban Acetate Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Atosiban Acetate Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Atosiban Acetate Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Atosiban Acetate Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Atosiban Acetate Injection Market Facts & Figures by Country
3.7.1 Latin America Atosiban Acetate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Atosiban Acetate Injection Sales by Country (2020-2031)
3.7.3 Latin America Atosiban Acetate Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atosiban Acetate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Atosiban Acetate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Atosiban Acetate Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Atosiban Acetate Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atosiban Acetate Injection Sales by Type (2020-2031)
4.1.1 Global Atosiban Acetate Injection Sales by Type (2020-2025)
4.1.2 Global Atosiban Acetate Injection Sales by Type (2026-2031)
4.1.3 Global Atosiban Acetate Injection Sales Market Share by Type (2020-2031)
4.2 Global Atosiban Acetate Injection Revenue by Type (2020-2031)
4.2.1 Global Atosiban Acetate Injection Revenue by Type (2020-2025)
4.2.2 Global Atosiban Acetate Injection Revenue by Type (2026-2031)
4.2.3 Global Atosiban Acetate Injection Revenue Market Share by Type (2020-2031)
4.3 Global Atosiban Acetate Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Atosiban Acetate Injection Sales by Application (2020-2031)
5.1.1 Global Atosiban Acetate Injection Sales by Application (2020-2025)
5.1.2 Global Atosiban Acetate Injection Sales by Application (2026-2031)
5.1.3 Global Atosiban Acetate Injection Sales Market Share by Application (2020-2031)
5.2 Global Atosiban Acetate Injection Revenue by Application (2020-2031)
5.2.1 Global Atosiban Acetate Injection Revenue by Application (2020-2025)
5.2.2 Global Atosiban Acetate Injection Revenue by Application (2026-2031)
5.2.3 Global Atosiban Acetate Injection Revenue Market Share by Application (2020-2031)
5.3 Global Atosiban Acetate Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bachem
6.1.1 Bachem Company Information
6.1.2 Bachem Description and Business Overview
6.1.3 Bachem Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bachem Atosiban Acetate Injection Product Portfolio
6.1.5 Bachem Recent Developments/Updates
6.2 Piramal Pharma Solutions
6.2.1 Piramal Pharma Solutions Company Information
6.2.2 Piramal Pharma Solutions Description and Business Overview
6.2.3 Piramal Pharma Solutions Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Piramal Pharma Solutions Atosiban Acetate Injection Product Portfolio
6.2.5 Piramal Pharma Solutions Recent Developments/Updates
6.3 Transo-Pharm
6.3.1 Transo-Pharm Company Information
6.3.2 Transo-Pharm Description and Business Overview
6.3.3 Transo-Pharm Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Transo-Pharm Atosiban Acetate Injection Product Portfolio
6.3.5 Transo-Pharm Recent Developments/Updates
6.4 Rochem International
6.4.1 Rochem International Company Information
6.4.2 Rochem International Description and Business Overview
6.4.3 Rochem International Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Rochem International Atosiban Acetate Injection Product Portfolio
6.4.5 Rochem International Recent Developments/Updates
6.5 Suanfarma
6.5.1 Suanfarma Company Information
6.5.2 Suanfarma Description and Business Overview
6.5.3 Suanfarma Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Suanfarma Atosiban Acetate Injection Product Portfolio
6.5.5 Suanfarma Recent Developments/Updates
6.6 Teva Pharmaceutical Industries
6.6.1 Teva Pharmaceutical Industries Company Information
6.6.2 Teva Pharmaceutical Industries Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceutical Industries Atosiban Acetate Injection Product Portfolio
6.6.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.7 PolyPeptide Group
6.7.1 PolyPeptide Group Company Information
6.7.2 PolyPeptide Group Description and Business Overview
6.7.3 PolyPeptide Group Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 PolyPeptide Group Atosiban Acetate Injection Product Portfolio
6.7.5 PolyPeptide Group Recent Developments/Updates
6.8 Emcure Pharmaceuticals
6.8.1 Emcure Pharmaceuticals Company Information
6.8.2 Emcure Pharmaceuticals Description and Business Overview
6.8.3 Emcure Pharmaceuticals Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Emcure Pharmaceuticals Atosiban Acetate Injection Product Portfolio
6.8.5 Emcure Pharmaceuticals Recent Developments/Updates
6.9 Smaart Pharmaceutticals
6.9.1 Smaart Pharmaceutticals Company Information
6.9.2 Smaart Pharmaceutticals Description and Business Overview
6.9.3 Smaart Pharmaceutticals Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Smaart Pharmaceutticals Atosiban Acetate Injection Product Portfolio
6.9.5 Smaart Pharmaceutticals Recent Developments/Updates
6.10 Omgene Life Sciences
6.10.1 Omgene Life Sciences Company Information
6.10.2 Omgene Life Sciences Description and Business Overview
6.10.3 Omgene Life Sciences Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Omgene Life Sciences Atosiban Acetate Injection Product Portfolio
6.10.5 Omgene Life Sciences Recent Developments/Updates
6.11 BCN Peptides
6.11.1 BCN Peptides Company Information
6.11.2 BCN Peptides Description and Business Overview
6.11.3 BCN Peptides Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BCN Peptides Atosiban Acetate Injection Product Portfolio
6.11.5 BCN Peptides Recent Developments/Updates
6.12 MSN Laboratories
6.12.1 MSN Laboratories Company Information
6.12.2 MSN Laboratories Description and Business Overview
6.12.3 MSN Laboratories Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 MSN Laboratories Atosiban Acetate Injection Product Portfolio
6.12.5 MSN Laboratories Recent Developments/Updates
6.13 Carbosynth
6.13.1 Carbosynth Company Information
6.13.2 Carbosynth Description and Business Overview
6.13.3 Carbosynth Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Carbosynth Atosiban Acetate Injection Product Portfolio
6.13.5 Carbosynth Recent Developments/Updates
6.14 Tecoland
6.14.1 Tecoland Company Information
6.14.2 Tecoland Description and Business Overview
6.14.3 Tecoland Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Tecoland Atosiban Acetate Injection Product Portfolio
6.14.5 Tecoland Recent Developments/Updates
6.15 Jigs Chemical
6.15.1 Jigs Chemical Company Information
6.15.2 Jigs Chemical Description and Business Overview
6.15.3 Jigs Chemical Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jigs Chemical Atosiban Acetate Injection Product Portfolio
6.15.5 Jigs Chemical Recent Developments/Updates
6.16 LGM Pharma
6.16.1 LGM Pharma Company Information
6.16.2 LGM Pharma Description and Business Overview
6.16.3 LGM Pharma Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.16.4 LGM Pharma Atosiban Acetate Injection Product Portfolio
6.16.5 LGM Pharma Recent Developments/Updates
6.17 Hangzhou Go Top Peptide Biotech
6.17.1 Hangzhou Go Top Peptide Biotech Company Information
6.17.2 Hangzhou Go Top Peptide Biotech Description and Business Overview
6.17.3 Hangzhou Go Top Peptide Biotech Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Hangzhou Go Top Peptide Biotech Atosiban Acetate Injection Product Portfolio
6.17.5 Hangzhou Go Top Peptide Biotech Recent Developments/Updates
6.18 Sun Pharmaceutical lndustrie
6.18.1 Sun Pharmaceutical lndustrie Company Information
6.18.2 Sun Pharmaceutical lndustrie Description and Business Overview
6.18.3 Sun Pharmaceutical lndustrie Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Sun Pharmaceutical lndustrie Atosiban Acetate Injection Product Portfolio
6.18.5 Sun Pharmaceutical lndustrie Recent Developments/Updates
6.19 Hainan Zhonghe
6.19.1 Hainan Zhonghe Company Information
6.19.2 Hainan Zhonghe Description and Business Overview
6.19.3 Hainan Zhonghe Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Hainan Zhonghe Atosiban Acetate Injection Product Portfolio
6.19.5 Hainan Zhonghe Recent Developments/Updates
6.20 Shanghai SOHO YIMING
6.20.1 Shanghai SOHO YIMING Company Information
6.20.2 Shanghai SOHO YIMING Description and Business Overview
6.20.3 Shanghai SOHO YIMING Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Shanghai SOHO YIMING Atosiban Acetate Injection Product Portfolio
6.20.5 Shanghai SOHO YIMING Recent Developments/Updates
6.21 Hybio Pharmaceutical
6.21.1 Hybio Pharmaceutical Company Information
6.21.2 Hybio Pharmaceutical Description and Business Overview
6.21.3 Hybio Pharmaceutical Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Hybio Pharmaceutical Atosiban Acetate Injection Product Portfolio
6.21.5 Hybio Pharmaceutical Recent Developments/Updates
6.22 Hainan Herui
6.22.1 Hainan Herui Company Information
6.22.2 Hainan Herui Description and Business Overview
6.22.3 Hainan Herui Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Hainan Herui Atosiban Acetate Injection Product Portfolio
6.22.5 Hainan Herui Recent Developments/Updates
6.23 Chengdu Shengnuo
6.23.1 Chengdu Shengnuo Company Information
6.23.2 Chengdu Shengnuo Description and Business Overview
6.23.3 Chengdu Shengnuo Atosiban Acetate Injection Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Chengdu Shengnuo Atosiban Acetate Injection Product Portfolio
6.23.5 Chengdu Shengnuo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atosiban Acetate Injection Industry Chain Analysis
7.2 Atosiban Acetate Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atosiban Acetate Injection Production Mode & Process Analysis
7.4 Atosiban Acetate Injection Sales and Marketing
7.4.1 Atosiban Acetate Injection Sales Channels
7.4.2 Atosiban Acetate Injection Distributors
7.5 Atosiban Acetate Injection Customer Analysis
8 Atosiban Acetate Injection Market Dynamics
8.1 Atosiban Acetate Injection Industry Trends
8.2 Atosiban Acetate Injection Market Drivers
8.3 Atosiban Acetate Injection Market Challenges
8.4 Atosiban Acetate Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Atosiban Acetate Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Atosiban Acetate Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Atosiban Acetate Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Atosiban Acetate Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Atosiban Acetate Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Atosiban Acetate Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Atosiban Acetate Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Atosiban Acetate Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Atosiban Acetate Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Atosiban Acetate Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Atosiban Acetate Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Atosiban Acetate Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Atosiban Acetate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atosiban Acetate Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Atosiban Acetate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Atosiban Acetate Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Atosiban Acetate Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Atosiban Acetate Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Atosiban Acetate Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Atosiban Acetate Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Atosiban Acetate Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Atosiban Acetate Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Atosiban Acetate Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Atosiban Acetate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Atosiban Acetate Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Atosiban Acetate Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Atosiban Acetate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Atosiban Acetate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Atosiban Acetate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Atosiban Acetate Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Atosiban Acetate Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Atosiban Acetate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Atosiban Acetate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Atosiban Acetate Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Atosiban Acetate Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Atosiban Acetate Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Atosiban Acetate Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Atosiban Acetate Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Atosiban Acetate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Atosiban Acetate Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Atosiban Acetate Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Atosiban Acetate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Atosiban Acetate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Atosiban Acetate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Atosiban Acetate Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Atosiban Acetate Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Atosiban Acetate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Atosiban Acetate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Atosiban Acetate Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Atosiban Acetate Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Atosiban Acetate Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Atosiban Acetate Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Atosiban Acetate Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Atosiban Acetate Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Atosiban Acetate Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Atosiban Acetate Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Atosiban Acetate Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Atosiban Acetate Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Atosiban Acetate Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Atosiban Acetate Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Atosiban Acetate Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Atosiban Acetate Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Atosiban Acetate Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Atosiban Acetate Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Atosiban Acetate Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Atosiban Acetate Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Atosiban Acetate Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Atosiban Acetate Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Bachem Company Information
 Table 71. Bachem Description and Business Overview
 Table 72. Bachem Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bachem Atosiban Acetate Injection Product
 Table 74. Bachem Recent Developments/Updates
 Table 75. Piramal Pharma Solutions Company Information
 Table 76. Piramal Pharma Solutions Description and Business Overview
 Table 77. Piramal Pharma Solutions Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Piramal Pharma Solutions Atosiban Acetate Injection Product
 Table 79. Piramal Pharma Solutions Recent Developments/Updates
 Table 80. Transo-Pharm Company Information
 Table 81. Transo-Pharm Description and Business Overview
 Table 82. Transo-Pharm Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Transo-Pharm Atosiban Acetate Injection Product
 Table 84. Transo-Pharm Recent Developments/Updates
 Table 85. Rochem International Company Information
 Table 86. Rochem International Description and Business Overview
 Table 87. Rochem International Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Rochem International Atosiban Acetate Injection Product
 Table 89. Rochem International Recent Developments/Updates
 Table 90. Suanfarma Company Information
 Table 91. Suanfarma Description and Business Overview
 Table 92. Suanfarma Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Suanfarma Atosiban Acetate Injection Product
 Table 94. Suanfarma Recent Developments/Updates
 Table 95. Teva Pharmaceutical Industries Company Information
 Table 96. Teva Pharmaceutical Industries Description and Business Overview
 Table 97. Teva Pharmaceutical Industries Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Teva Pharmaceutical Industries Atosiban Acetate Injection Product
 Table 99. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 100. PolyPeptide Group Company Information
 Table 101. PolyPeptide Group Description and Business Overview
 Table 102. PolyPeptide Group Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. PolyPeptide Group Atosiban Acetate Injection Product
 Table 104. PolyPeptide Group Recent Developments/Updates
 Table 105. Emcure Pharmaceuticals Company Information
 Table 106. Emcure Pharmaceuticals Description and Business Overview
 Table 107. Emcure Pharmaceuticals Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Emcure Pharmaceuticals Atosiban Acetate Injection Product
 Table 109. Emcure Pharmaceuticals Recent Developments/Updates
 Table 110. Smaart Pharmaceutticals Company Information
 Table 111. Smaart Pharmaceutticals Description and Business Overview
 Table 112. Smaart Pharmaceutticals Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Smaart Pharmaceutticals Atosiban Acetate Injection Product
 Table 114. Smaart Pharmaceutticals Recent Developments/Updates
 Table 115. Omgene Life Sciences Company Information
 Table 116. Omgene Life Sciences Description and Business Overview
 Table 117. Omgene Life Sciences Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Omgene Life Sciences Atosiban Acetate Injection Product
 Table 119. Omgene Life Sciences Recent Developments/Updates
 Table 120. BCN Peptides Company Information
 Table 121. BCN Peptides Description and Business Overview
 Table 122. BCN Peptides Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. BCN Peptides Atosiban Acetate Injection Product
 Table 124. BCN Peptides Recent Developments/Updates
 Table 125. MSN Laboratories Company Information
 Table 126. MSN Laboratories Description and Business Overview
 Table 127. MSN Laboratories Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. MSN Laboratories Atosiban Acetate Injection Product
 Table 129. MSN Laboratories Recent Developments/Updates
 Table 130. Carbosynth Company Information
 Table 131. Carbosynth Description and Business Overview
 Table 132. Carbosynth Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Carbosynth Atosiban Acetate Injection Product
 Table 134. Carbosynth Recent Developments/Updates
 Table 135. Tecoland Company Information
 Table 136. Tecoland Description and Business Overview
 Table 137. Tecoland Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Tecoland Atosiban Acetate Injection Product
 Table 139. Tecoland Recent Developments/Updates
 Table 140. Jigs Chemical Company Information
 Table 141. Jigs Chemical Description and Business Overview
 Table 142. Jigs Chemical Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Jigs Chemical Atosiban Acetate Injection Product
 Table 144. Jigs Chemical Recent Developments/Updates
 Table 145. LGM Pharma Company Information
 Table 146. LGM Pharma Description and Business Overview
 Table 147. LGM Pharma Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. LGM Pharma Atosiban Acetate Injection Product
 Table 149. LGM Pharma Recent Developments/Updates
 Table 150. Hangzhou Go Top Peptide Biotech Company Information
 Table 151. Hangzhou Go Top Peptide Biotech Description and Business Overview
 Table 152. Hangzhou Go Top Peptide Biotech Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Hangzhou Go Top Peptide Biotech Atosiban Acetate Injection Product
 Table 154. Hangzhou Go Top Peptide Biotech Recent Developments/Updates
 Table 155. Sun Pharmaceutical lndustrie Company Information
 Table 156. Sun Pharmaceutical lndustrie Description and Business Overview
 Table 157. Sun Pharmaceutical lndustrie Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Sun Pharmaceutical lndustrie Atosiban Acetate Injection Product
 Table 159. Sun Pharmaceutical lndustrie Recent Developments/Updates
 Table 160. Hainan Zhonghe Company Information
 Table 161. Hainan Zhonghe Description and Business Overview
 Table 162. Hainan Zhonghe Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Hainan Zhonghe Atosiban Acetate Injection Product
 Table 164. Hainan Zhonghe Recent Developments/Updates
 Table 165. Shanghai SOHO YIMING Company Information
 Table 166. Shanghai SOHO YIMING Description and Business Overview
 Table 167. Shanghai SOHO YIMING Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Shanghai SOHO YIMING Atosiban Acetate Injection Product
 Table 169. Shanghai SOHO YIMING Recent Developments/Updates
 Table 170. Hybio Pharmaceutical Company Information
 Table 171. Hybio Pharmaceutical Description and Business Overview
 Table 172. Hybio Pharmaceutical Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Hybio Pharmaceutical Atosiban Acetate Injection Product
 Table 174. Hybio Pharmaceutical Recent Developments/Updates
 Table 175. Hainan Herui Company Information
 Table 176. Hainan Herui Description and Business Overview
 Table 177. Hainan Herui Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Hainan Herui Atosiban Acetate Injection Product
 Table 179. Hainan Herui Recent Developments/Updates
 Table 180. Chengdu Shengnuo Company Information
 Table 181. Chengdu Shengnuo Description and Business Overview
 Table 182. Chengdu Shengnuo Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Chengdu Shengnuo Atosiban Acetate Injection Product
 Table 184. Chengdu Shengnuo Recent Developments/Updates
 Table 185. Key Raw Materials Lists
 Table 186. Raw Materials Key Suppliers Lists
 Table 187. Atosiban Acetate Injection Distributors List
 Table 188. Atosiban Acetate Injection Customers List
 Table 189. Atosiban Acetate Injection Market Trends
 Table 190. Atosiban Acetate Injection Market Drivers
 Table 191. Atosiban Acetate Injection Market Challenges
 Table 192. Atosiban Acetate Injection Market Restraints
 Table 193. Research Programs/Design for This Report
 Table 194. Key Data Information from Secondary Sources
 Table 195. Key Data Information from Primary Sources
 Table 196. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Atosiban Acetate Injection
 Figure 2. Global Atosiban Acetate Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Atosiban Acetate Injection Market Share by Type: 2024 & 2031
 Figure 4. 0.9 ml Product Picture
 Figure 5. 5 ml Product Picture
 Figure 6. Global Atosiban Acetate Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Atosiban Acetate Injection Market Share by Application: 2024 & 2031
 Figure 8. Threatened Preterm Birth
 Figure 9. Inhibits Lactation
 Figure 10. Others
 Figure 11. Global Atosiban Acetate Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Atosiban Acetate Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Atosiban Acetate Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Atosiban Acetate Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Atosiban Acetate Injection Report Years Considered
 Figure 16. Atosiban Acetate Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Atosiban Acetate Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Atosiban Acetate Injection Players: Market Share by Revenue in Atosiban Acetate Injection in 2024
 Figure 19. Atosiban Acetate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Atosiban Acetate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Atosiban Acetate Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Atosiban Acetate Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Atosiban Acetate Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Atosiban Acetate Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Atosiban Acetate Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Atosiban Acetate Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Atosiban Acetate Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Atosiban Acetate Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Atosiban Acetate Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Atosiban Acetate Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Atosiban Acetate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Atosiban Acetate Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Atosiban Acetate Injection by Type (2020-2031)
 Figure 53. Global Atosiban Acetate Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Atosiban Acetate Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Atosiban Acetate Injection by Application (2020-2031)
 Figure 56. Global Atosiban Acetate Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Atosiban Acetate Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure